# EDGAR Filing Document

**Accession Number:** 0001957114
**File Stem:** 0001957114-26-000001
**Filing Date:** 2026-5
**Character Count:** 2981
**Document Hash:** bec87854044b83e06da9398e19af32f0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001957114-26-000001.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001957114-26-000001

**CONFORMED SUBMISSION TYPE**: C-AR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iMetabolic Biopharma Corp
- **CENTRAL INDEX KEY:** 0001957114

**ORGANIZATION NAME:**
- **EIN:** 823644889
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-31493
- **FILM NUMBER:** 26947284

**BUSINESS ADDRESS:**
- **STREET 1:** 2155 E CONFERENCE DR.
- **STREET 2:** STE 115
- **CITY:** TEMPE
- **STATE:** AZ
- **ZIP:** 85284
- **BUSINESS PHONE:** 480-939-5770

**MAIL ADDRESS:**
- **STREET 1:** 275 N GATEWAY DR, SUITE 104
- **STREET 2:** SUITE 104
- **CITY:** PHOENIX
- **STATE:** AZ
- **ZIP:** 85034

### Attached PDF Documents

**Attachment 1:** `form_car.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** iMetabolic Biopharma Corporation

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** NV

**Date of Organization:** 11-17-2017

**Physical Address:** 275 N Gateway Dr, Suite 104, Phoenix, AZ, 85034

**Issuer Website:** https://imbiopharma.com/

**Is there a Co-Issuer?:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 4

**Total Assets (Most Recent Fiscal Year):** $27,787.00

**Total Assets (Prior Fiscal Year):** $82,459.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $25,726.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $82,459.00

**Accounts Receivable (Most Recent Fiscal Year):** $2.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $65,378.00

**Short-Term Debt (Prior Fiscal Year):** $47,853.00

**Long-Term Debt (Most Recent Fiscal Year):** $557,779.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $137,329.00

**Revenues/Sales (Prior Fiscal Year):** $129,520.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-99,746.00

**Net Income (Prior Fiscal Year):** $-120,292.00

### Signatures

**Issuer:** iMetabolic Biopharma Corporation

**Signature:** Urban Kiernan

**Title:** CEO and Chairman

---

**Signature:** Urban Kiernan

**Title:** CEO and Chairman

**Date:** 05-05-2026

---

**Signature:** Urban Kiernan

**Title:** CFO

**Date:** 05-05-2026

---

**Signature:** Jeffrey Zimmerman

**Title:** Director and General Counsel

**Date:** 05-05-2026